Karki B, Sherpa TW, Deo RK, Thapa P. Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal. J Patan Acad Health Sci [Internet]. 2024 Jun. 14 [cited 2024 Dec. 3];11(1):21-6. Available from: https://nepjol.info/index.php/JPAHS/article/view/65652